TrialJID innovations : skin science from molecules to population health2021

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.

Takashi Nomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.